Prestige Consumer Healthcare (NYSE:PBH) executives told investors the company delivered “solid” fiscal third-quarter results amid what management described as a highly volatile consumer and retail environment, while continuing to work through supply constraints in its Clear Eyes brand. On the company’s earnings call, leadership also narrowed its full-year fiscal 2026 revenue outlook to approximately $1.1 [...]
Prestige Consumer Healthcare Q3 Earnings Call Highlights
